Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2006-04-18
2006-04-18
Epps-Ford, Janet L. (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C536S023100, C435S325000, C435S375000, C424S093210
Reexamination Certificate
active
07029665
ABSTRACT:
Novel synthetic suppressor tRNA have been provided which provide read-through of internal nonsense mutations, or which can site-specifically alter translation of transcribed sequences. Uses of the same are also provided in genetic engineering protocols including gene therapy treatment of diseases such as Xeroderma pigmentosum.
REFERENCES:
patent: 4687737 (1987-08-01), Sharp et al.
patent: 4970155 (1990-11-01), Okasinski
patent: 5861501 (1999-01-01), Benseler et al.
patent: 6309830 (2001-10-01), Panchal et al.
Temple et al., Construction of a functional human suppressor tRNA gene: an approach to gene therapy for b-thalassaemia, Nature, 337-340.
Li et al., Ochre Suppressor Transfer RNA restored dystrophin expression in MDX mice, Life Sciences, 61(15): 205-209.
Noren et al., A General Method for Site-Specific Incorporation of Unnatural Amino Acids into Proteins, Science, 244: 182-188.
Atkinson, et al., Mutations to nonsense codons in human genetic disease: implications for gene therapy by nonsense suppressor tRNAs, Nucleic Acid Res, 22(8): 1327-1334.
Capone et al. EMBO, vol. 4, No. 1, pp. 213-221. See IDS filed Oct. 30, 2001.
Beier et al. Misreading of termination codons in eukaryotes by natural nonsense suppresor tRNAs. Dec. 2001, vol. 29, No. 23, pp. 4767-4782.
Capone, J. DNA. vol. 7, No. 7, pp. 459-468. 1988.
Sprinzl et al. Compliation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Research, vol. 26, No. 1, pp. 148-153, Jan. 1998.
Roy et al. Nucleic acids Research, vol. 10, No. 23, pp. 7313-7321, 1982.
Green et al. The Journal of Biological Chemistry. vol. 265, No. 21, pp. 12139-12142, Jul. 1990.
Arnold et al. DNA, vol. 7, No. 2, pp. 87-97, 1988.
O'Neill VA et al., “A human opal suppressor tRNA gene and pseudogene”,Journal of Biological Chemistry, 260(4) 2501-2508 (1985).
Robinson, et al., “Suppression of single and double nonsense mutations introduced into the diphtheria toxin A-chain gene: a potential binary system for toxin gene therapy”,Human Gene Therapy, 6:137-143 (1995).
Temple GF, et al., “Construction of a functional human suppressor tRNA gene: an approach to gene therapy for β-thalassaemia”,Nature, 296(5857) 537-540 (1982).
Zhang, et al., “Ochre suppressor transfer RNA restorer dystrophin expression in mdx mice”,Life Sciences, 61(15):205-209 (1998).
Link, Jr. Charles J.
Panchal Rekha G.
Epps-Ford Janet L.
Human Gene Therapy Research Institute
McKee Voorhees & Sease, P.L.C.
LandOfFree
Human suppressor tRNA oligonucleotides and methods for use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human suppressor tRNA oligonucleotides and methods for use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human suppressor tRNA oligonucleotides and methods for use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3607893